NOVEMBER 2026 • ISSUE 215 • ARTICLE 2

Article 3

Dr. Priscilla White

Beyond Blood Sugar: How Dapagliflozin May Protect the Kidneys in Diabetes

Sodium-glucose cotransporter 2 (SGLT2) inhibitors, such as dapagliflozin, are widely recognized for their kidney-protective benefits in people with diabetic kidney disease (DKD). Interestingly, these benefits extend beyond their ability to lower blood glucose, although the underlying mechanisms are not fully understood. New research points to ferroptosis, a form of regulated cell death driven by iron accumulation and lipid damage, as a potential contributor to kidney injury in diabetes. The study identified increased activity of Yes-associated protein 1 (YAP) in human DKD kidney tissue and found that it was associated with higher levels of ferroptosis-related markers, including ACSL4 and 4-hydroxynonenal. Greater YAP activity was also associated with poorer kidney function, suggesting a possible link between this pathway and the progression of renal damage.

In experiments involving diabetic rats and kidney tubular cells exposed to high glucose, dapagliflozin reduced kidney dysfunction, tubular injury and fibrosis, alongside decreased YAP activation and ferroptosis. The researchers found that YAP promotes the expression of proteins involved in iron accumulation and cellular damage, including ACSL4, thereby contributing to the death of renal tubular cells. Further investigations identified a molecular pathway involving YAP and TEAD4, which together activate the ACSL4 gene. Dapagliflozin suppressed this activity, suggesting a possible mechanism behind its kidney-protective effects beyond glucose lowering. These findings highlight the YAP/TEAD4/ACSL4 pathway as a potential therapeutic target for diabetic kidney disease. However, the evidence comes from tissue analyses and preclinical experiments, and further studies are needed to establish how directly this mechanism contributes to kidney protection in patients.

Explore More →

Choose your branch

Tap a branch to call and book an appointment.